Scheicher M E, Teixeira M M, Cunha F Q, Teixeira A L, Filho J T, Vianna E O
Dept of Medicine, University of S. Paulo Medical School at Ribeirão Preto, Av. Bandeirantes 3900, Ribeirão Preto, Sãu Paulo, 14048-900, Brazil.
Eur Respir J. 2007 Mar;29(3):489-95. doi: 10.1183/09031936.00060205. Epub 2006 Nov 1.
The aim of the present study was to elucidate whether the culture of cells recovered from induced sputum may represent a suitable model to evaluate cytokine and chemokine production by airway inflammatory cells. Sputum induction was performed in 21 normal subjects and 30 asthmatic patients. A total of 21 out of the 30 asthmatic patients were taking inhaled corticosteroids, while the remaining nine were steroid-naive asthmatics. The steroid-naive group was evaluated before and after a 14-day treatment with oral prednisone (40 mg.day(-1)). The supernatant of lysed and centrifuged sputum and the supernatant of sputum cell culture were analysed. Tumour necrosis factor-alpha, interleukin (IL)-8 (CXCL8), IL-1beta, IL-13 and eotaxin-2 (CCL24) concentrations were determined by specific ELISA. Eotaxin-2 production by cell culture was higher in the asthma group (131+/-108 pg.mL(-1)) than in the control group (36+/-41 pg.mL(-1)) and treatment with oral corticosteroids eliminated this difference. In addition, reduction of eotaxin-2 levels by corticosteroid treatment was greater in cell culture (81.3% reduction) than in sputum (26.4%). There was correlation between the decrease in eotaxin-2 production and the decrease in blood eosinophil number and between eotaxin-2 and eosinophils in sputum. Eotaxin-2 may play an important role in asthma and the response to corticosteroid treatment suggests that analysis of sputum cell culture is relevant as an inflammatory parameter.
本研究的目的是阐明诱导痰中回收的细胞培养是否可作为评估气道炎症细胞产生细胞因子和趋化因子的合适模型。对21名正常受试者和30名哮喘患者进行了痰液诱导。30名哮喘患者中共有21名正在吸入糖皮质激素,其余9名是未使用过类固醇的哮喘患者。对未使用过类固醇的组在口服泼尼松(40mg·天⁻¹)治疗14天前后进行评估。分析了裂解并离心后的痰液上清液和痰液细胞培养上清液。通过特异性酶联免疫吸附测定法测定肿瘤坏死因子-α、白细胞介素(IL)-8(CXCL8)、IL-1β、IL-13和嗜酸性粒细胞趋化因子-2(CCL24)的浓度。哮喘组细胞培养产生的嗜酸性粒细胞趋化因子-2(131±108pg·mL⁻¹)高于对照组(36±41pg·mL⁻¹),口服糖皮质激素治疗消除了这种差异。此外,糖皮质激素治疗使细胞培养中嗜酸性粒细胞趋化因子-2水平的降低幅度(降低81.3%)大于痰液中(降低26.4%)。嗜酸性粒细胞趋化因子-2产生的减少与血液嗜酸性粒细胞数量的减少之间以及与痰液中嗜酸性粒细胞之间存在相关性。嗜酸性粒细胞趋化因子-2可能在哮喘中起重要作用,对糖皮质激素治疗的反应表明痰液细胞培养分析作为一种炎症参数具有相关性。